Themis Medicare Executive and Leadership Team

Tushar Dalal, the Chief Financial Officer at Themis Medicare, manages the fiscal strategy and capital allocation for pharmaceutical manufacturing operations. Dalal oversees the financial planning for research and development investments in cardiology and pain management sectors. By monitoring cash flow and cost structures, the Chief Financial Officer ensures the long-term profitability of medicinal chemical production. This leadership role involves coordinating with the board to evaluate market expansion opportunities across emerging economies. Tushar Dalal drives the optimization of procurement budgets to stabilize the supply of raw materials for anti-infectives and health supplements. Through rigorous financial auditing and risk assessment, the Chief Financial Officer maintains the fiscal health of the organization. Ultimately, Dalal secures the necessary capital to support ongoing innovation in drug formulation while ensuring consistent shareholder value and operational efficiency within the competitive pharmaceutical landscape.

Prakash Naringrekar, the Chief Financial Officer & Company Secretary at Themis Medicare, governs corporate compliance and regulatory reporting standards. Naringrekar oversees the legal documentation for pharmaceutical manufacturing licenses and ensures adherence to statutory requirements in the Indian market. By managing investor relations and board communications, the Chief Financial Officer & Company Secretary facilitates transparent governance practices. This leadership role involves supervising the internal audit functions to verify the accuracy of financial statements related to haematinics and nutrition products. Prakash Naringrekar drives the implementation of corporate policies that align with international pharmaceutical regulations. Through the oversight of shareholder meetings and regulatory filings, the Chief Financial Officer & Company Secretary maintains the legal integrity of the company. Ultimately, Naringrekar secures the organizational framework required for sustainable growth and ethical conduct within the complex regulatory environment of the global pharmaceutical industry.

Hoshang Messman, the President, International Business Development at Themis Medicare, architects the global market entry strategy for cardiology and pain management portfolios. Messman oversees the expansion of distribution networks across international territories to increase the reach of anti-infectives and medicinal chemicals. By identifying strategic partnerships with global healthcare providers, the President, International Business Development drives revenue growth in diverse geographic regions. This leadership role involves analyzing market trends to tailor product offerings for specific international health and nutrition requirements. Hoshang Messman directs the negotiation of export agreements and ensures compliance with foreign regulatory standards. Through the cultivation of long-term relationships with global distributors, the President, International Business Development strengthens the brand presence of the company. Ultimately, Messman secures a competitive advantage by positioning the organization as a reliable supplier of high-quality pharmaceuticals in the global marketplace.

Muraridutt Sharma, the President at Themis Medicare, directs the overarching strategic vision and operational execution for the entire pharmaceutical enterprise. Sharma oversees the alignment of manufacturing capabilities with the evolving demands of the cardiology, pain management, and anti-infective sectors. By coordinating the efforts of all C-suite leaders, the President ensures the seamless integration of research, production, and commercial functions. This leadership role involves setting long-term objectives for market penetration and product innovation. Muraridutt Sharma drives the development of high-performance teams focused on delivering superior medicinal chemicals and health solutions. Through the continuous evaluation of operational efficiency and quality standards, the President maintains the reputation of the company as a leader in the pharmaceutical industry. Ultimately, Sharma secures the future trajectory of the organization by fostering a culture of excellence and innovation across all regional and functional departments.

Reena Patel, the Chief Information Officer at Themis Medicare, directs the digital transformation of pharmaceutical manufacturing processes. Patel oversees the integration of advanced data analytics to optimize supply chain visibility across the Indian market. By architecting secure cloud infrastructure, the Chief Information Officer ensures compliance with international data protection standards for sensitive medicinal research. This leadership role involves streamlining internal communication platforms to enhance cross-departmental collaboration between research teams and production facilities. Reena Patel drives the implementation of automated quality control systems, reducing operational latency in the development of anti-infectives and haematinics. Through the deployment of robust cybersecurity frameworks, the Chief Information Officer protects proprietary chemical formulas and intellectual property. Ultimately, Patel secures the technological foundation necessary for scaling production capacity while maintaining the rigorous precision required for cardiology and pain management product lines.